{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T12:02:58Z","timestamp":1772020978662,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2006,11,16]],"date-time":"2006-11-16T00:00:00Z","timestamp":1163635200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2007,3,14]]},"DOI":"10.1007\/s00259-006-0251-y","type":"journal-article","created":{"date-parts":[[2006,11,15]],"date-time":"2006-11-15T22:46:55Z","timestamp":1163630815000},"page":"472-479","source":"Crossref","is-referenced-by-count":73,"title":["Post-therapy surveillance of patients with uterine cancers: value of integrated FDG PET\/CT in the detection of recurrence"],"prefix":"10.1007","volume":"34","author":[{"given":"Sandro","family":"Sironi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Picchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Landoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Galimberti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Signorelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentino","family":"Bettinardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Perego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Costantino","family":"Mangioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Messa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferruccio","family":"Fazio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,11,16]]},"reference":[{"key":"251_CR1","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJM199608293350907","volume":"335","author":"PG Rose","year":"1996","unstructured":"Rose PG. Endometrial carcinoma. N Engl J Med 1996;335:640\u20139.","journal-title":"N Engl J Med"},{"key":"251_CR2","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1016\/S0140-6736(03)13778-6","volume":"361","author":"SE Waggoner","year":"2003","unstructured":"Waggoner SE. Cervical cancer. Lancet 2003;361:2217\u201325.","journal-title":"Lancet"},{"key":"251_CR3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0020-7292(00)90001-8","volume":"70","author":"JL Benedet","year":"2000","unstructured":"Benedet JL, Bender H, Jones H, Ngan HY, Pecorelli S. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynecol Obstet 2000;70:209\u201362.","journal-title":"Int J Gynecol Obstet"},{"key":"251_CR4","first-page":"89","volume-title":"Clinical gynecologic oncology","author":"PJ Disaia","year":"2001","unstructured":"Disaia PJ, Creasman WT. Clinical gynecologic oncology. 6th ed. St. Louis: Mosby; 2001; p 89\u201393.","edition":"6"},{"key":"251_CR5","first-page":"1433","volume-title":"Cancer. Principles and practice of oncology","author":"PJ Eifel","year":"1997","unstructured":"Eifel PJ, Berek JS, Thigpen JT. Cancer of the cervix, vagina and vulva. In: de Vita VTJ, Hellman S, Rosenberg SA, editors. Cancer. Principles and practice of oncology. 5th ed., Philadelphia: Lippincott-Raven; 1997; p 1433\u201378.","edition":"5"},{"key":"251_CR6","unstructured":"Barakat RR, Greven K, Markman M, Thigpen JT. Cancer management. A multi-disciplinary approach. In: Endometrial cancer. 5th ed. New York: PRR Inc; 2001."},{"key":"251_CR7","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/j.1471-0528.1997.tb10979.x","volume":"104","author":"HB Salvesen","year":"1997","unstructured":"Salvesen HB, Akslen LA, Iversen T, Iversen OE. Recurrence of endometrial carcinoma and the value of routine follow-up. Br J Obstet Gynaecol 1997;104:1302\u20137.","journal-title":"Br J Obstet Gynaecol"},{"key":"251_CR8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1006\/gyno.2000.5860","volume":"78","author":"D Bodurka-Bevers","year":"2000","unstructured":"Bodurka-Bevers D, Morris M, Eifel PJ, Levenback C, Bevers MW, Lucas KR, et al. Posttherapy surveillance of women with cervical cancer: an outcomes analysis. Gynecol Oncol 2000;78:187\u201393.","journal-title":"Gynecol Oncol"},{"key":"251_CR9","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1046\/j.1525-1438.2001.01042.x","volume":"11","author":"A Olaitan","year":"2001","unstructured":"Olaitan A, Murdoch J, Anderson R, James J, Graham J, Barley V. A critical evaluation of current protocols for the follow-up of women treated for gynecological malignancies: a pilot study. Int J Gynecol Cancer 2001;11:349\u201353.","journal-title":"Int J Gynecol Cancer"},{"key":"251_CR10","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1006\/gyno.2001.6532","volume":"84","author":"M Maiman","year":"2002","unstructured":"Maiman M. The clinical application of serum squamous cell carcinoma antigen level monitoring in invasive cervical carcinoma. Gynecol Oncol 2002;84:4\u20136.","journal-title":"Gynecol Oncol"},{"key":"251_CR11","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1006\/gyno.1998.5018","volume":"69","author":"T Kurihara","year":"1998","unstructured":"Kurihara T, Mizunuma H, Obara M, Andoh K, Ibuki Y, Nishimura T. Determination of a normal level of serum CA 125 in postmenopausal women as a tool for preoperative evaluation and postoperative surveillance of endometrial carcinoma. Gynecol Oncol 1998;69:192\u20136.","journal-title":"Gynecol Oncol"},{"key":"251_CR12","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1148\/radiology.166.2.3422025","volume":"166","author":"F Ebner","year":"1988","unstructured":"Ebner F, Kressel HY, Mintz MC, Carlson JA, Cohen EK, Schiebler M, et al. Tumor recurrence versus fibrosis in the female pelvis: differentiation with MR imaging at 1.5\u00a0T. Radiology 1988;166:333\u201340.","journal-title":"Radiology"},{"key":"251_CR13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1148\/radiology.194.1.7997540","volume":"194","author":"TM Weber","year":"1995","unstructured":"Weber TM, Sostman HD, Spritzer CE, Ballard RL. Cervical carcinoma: determination of recurrent tumor extent versus radiation changes with MR imaging.Radiology 1995;194:135\u20139.","journal-title":"Radiology"},{"key":"251_CR14","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2214\/ajr.166.2.8553955","volume":"166","author":"H Hawighorst","year":"1996","unstructured":"Hawighorst H, Knapstein PG, Schaeffer U, Knopp MV, Brix G, Hoffmann U, et al. Pelvic lesions in patients with cervical carcinoma: efficacy of pharmacokinetic analysis of dynamic MR images in distinguishing recurrent tumors from benign conditions. AJR 1996;166:401\u20138.","journal-title":"AJR"},{"key":"251_CR15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/jmri.1880060130","volume":"1","author":"Y Yamashita","year":"1996","unstructured":"Yamashita Y, Harada M, Torashima M, Takahashi M, Miyazaki K, Tanaka N, et al. Dynamic MR imaging of recurrent postoperative cervical cancer. J Magn Reson Imaging 1996;1:167\u201371.","journal-title":"J Magn Reson Imaging"},{"key":"251_CR16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1148\/radiology.204.1.9205223","volume":"204","author":"K Kinkel","year":"1997","unstructured":"Kinkel K, Ariche M, Tardivon AA, Spatz A, Castaigne D, Lhomme C, et al. Differentiation between recurrent tumor and benign conditions after treatment of gynaecologic pelvic carcinoma: value of dynamic contrast-enhanced subtraction MR imaging. Radiology 1997;204:55\u201363.","journal-title":"Radiology"},{"key":"251_CR17","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2214\/ajr.175.3.1750759","volume":"175","author":"WT Yang","year":"2000","unstructured":"Yang WT, Lam WW, Yu MY, Cheung TH, Metreweli C. Comparison of dynamic helical CT and dynamic MR imaging in the evaluation of pelvic lymph nodes in cervical carcinoma. AJR 2000;175:759\u201368.","journal-title":"AJR"},{"key":"251_CR18","first-page":"692","volume":"95","author":"JP Connor","year":"2000","unstructured":"Connor JP, Andrews JI, Anderson B, Buller RE. Computed tomography in endometrial carcinoma. Obstet Gynecol 2000;95:692\u20136.","journal-title":"Obstet Gynecol"},{"key":"251_CR19","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1148\/radiol.2312021185","volume":"231","author":"EM Rohren","year":"2004","unstructured":"Rohren EM, Turkington TG, Coleman RE. Clinical applications of PET in oncology. Radiology 2004;231:305\u201332.","journal-title":"Radiology"},{"key":"251_CR20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1148\/radiology.200.1.8657901","volume":"200","author":"Y Anzai","year":"1996","unstructured":"Anzai Y, Carroll WR, Quint DJ, Bradford CR, Minoshima S, Wolf GT, et al. Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of FDG PET and MR imaging diagnoses. Radiology 1996;200:135\u201341.","journal-title":"Radiology"},{"key":"251_CR21","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1200\/JCO.2000.18.8.1689","volume":"18","author":"M Schelling","year":"2000","unstructured":"Schelling M, Avril N, Nahrig J, Kuhn W, Romer W, Sattler D, et al. Positron emission tomography using FDG for monitoring primary chemotheapy in breast cancer. J Clin Oncol 2000;18:1689\u201395.","journal-title":"J Clin Oncol"},{"key":"251_CR22","first-page":"492","volume":"43","author":"V Kalff","year":"2002","unstructured":"Kalff V, Hicks RJ, Ware RE, Hogg A, Binns D, McKenzie AF. The clinical impact of 18F-FDG PET in patients with suspected or confirmed recurrence of colorectal cancer: a prospective study. J Nucl Med 2002;43:492\u20139.","journal-title":"J Nucl Med"},{"key":"251_CR23","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.2214\/ajr.176.6.1761449","volume":"176","author":"Y Nakamoto","year":"2001","unstructured":"Nakamoto Y, Saga T, Ishimori T, Mamede M, Togashi K, Higuchi T, et al. Clinical value of positron emission tomography with FDG for recurrent ovarian cancer. AJR Am J Roentgenol 2001;176:1449\u201354.","journal-title":"AJ R Am J Roentgenol"},{"key":"251_CR24","first-page":"1125","volume":"40","author":"Y Sugawara","year":"1999","unstructured":"Sugawara Y, Eisbruch A, Kosuda S, Recker BE, Kison PV, Wahl R. Evaluation of FDG PET in patients with cervical cancer. J Nucl Med 1999;40:1125\u201331.","journal-title":"J Nucl Med"},{"key":"251_CR25","first-page":"2957","volume":"21","author":"SS Sun","year":"2001","unstructured":"Sun SS, Chen TC, Yen RF, Shen YY, Changlai SP, Kao A. Value of whole body FDG PET in the evaluation of recurrent cervical cancer. Anticancer Res 2001;21:2957\u201362.","journal-title":"Anticancer Res"},{"key":"251_CR26","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1007\/s00259-002-0878-2","volume":"29","author":"T Belhocine","year":"2002","unstructured":"Belhocine T, De Barsy C, Hustinx R, Willems-Foidart J. Usefulness of FDG PET in the posttherapy surveillance of endometrial carcinoma. Eur J Nucl Med Mol Imaging 2002;29:1132\u20139.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"251_CR27","first-page":"347","volume":"44","author":"SY Ryu","year":"2003","unstructured":"Ryu SY, Kim MH, Choi SC, Choi CW, Lee KH. Detection of early recurrence with FDG PET in patients with cervical cancer. J Nucl Med 2003;44:347\u201352.","journal-title":"J Nucl Med"},{"key":"251_CR28","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1200\/JCO.2004.09.035","volume":"22","author":"PW Grigsby","year":"2004","unstructured":"Grigsby PW, Siegel BA, Dehdashti F, Rader J, Zoberi I. Posttherapy FDG PET in carcinoma of the cervix: response and outcome. J Clin Oncol 2004;22:2167\u201371.","journal-title":"J Clin Oncol"},{"key":"251_CR29","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0360-3016(02)04287-6","volume":"55","author":"PW Grigsby","year":"2003","unstructured":"Grigsby PW, Siegel BA, Dehdashti F, Mutch DG. Post-therapy surveillance monitoring of cervical cancer by FDG PET. Int J Radiat Oncol Biol Phys 2003;55:907\u201313.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"251_CR30","first-page":"533","volume":"42","author":"DW Townsend","year":"2001","unstructured":"Townsend DW. A combined PET\/CT scanner. J Nucl Med 2001;42:533\u20134.","journal-title":"J Nucl Med"},{"key":"251_CR31","first-page":"1200","volume":"44","author":"R Bar-Shalom","year":"2003","unstructured":"Bar-Shalom R, Yefremov N, Guralnik L, Gaitini D, Frenkel A, Kuten A, et al. Clinical performance of PET\/CT in evaluation of cancer: additional value for diagnostic imaging and patient management. J Nucl Med 2003;44:1200\u20139.","journal-title":"J Nucl Med"},{"key":"251_CR32","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1148\/radiol.2341031554","volume":"234","author":"A Gutzeit","year":"2005","unstructured":"Gutzeit A, Antoch G, Kuhl H, Egelhof T, Fischer M, Hauth E, et al. Unknown primary tumors: detection with dual-modality PET\/CT. Initial experience. Radiology 2005;234:227\u201334.","journal-title":"Radiology"},{"key":"251_CR33","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1148\/radiol.2323031065","volume":"232","author":"E Even-Sapir","year":"2004","unstructured":"Even-Sapir E, Parag Y, Lerman H, Gutman M, Levine C, Rabau M, et al. Detection of recurrence in patients with rectal cancer: PET\/CT after abdominoperineal or anterior resection. Radiology 2004;232:815\u201322.","journal-title":"Radiology"},{"key":"251_CR34","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1148\/radiol.2332031800","volume":"233","author":"S Sironi","year":"2004","unstructured":"Sironi S, Messa C, Mangili G, Zangheri B, Aletti G, Garavaglia E, et al. Integrated FDG PET\/CT in patients with persistent ovarian cancer: correlation with histopathologic findings. Radiology 2004;233:433\u201340.","journal-title":"Radiology"},{"key":"251_CR35","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1600-0765.1997.tb00544.x","volume":"32","author":"C Ahn","year":"1997","unstructured":"Ahn C. Statistical methods for the estimation of sensitivity and specificity of site-specific diagnostic test. J Periodontal Res 1997;32:351\u20134.","journal-title":"J Periodontal Res"},{"key":"251_CR36","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1214\/ss\/1009213286","volume":"16","author":"LD Brown","year":"2001","unstructured":"Brown LD, Cai TT, Das Gupta A. Interval estimation for a binomial proportion. Stat Sci 2001;16:101\u201333.","journal-title":"Stat Sci"},{"key":"251_CR37","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF02990022","volume":"17","author":"T Saga","year":"2003","unstructured":"Saga T, Higashi T, Ishimori T, Mamede M, Nakamoto Y, Mukai T, et al. Clinical value of FDG-PET in the follow-up of postoperative patients with endometrial cancer. Ann Nucl Med 2003;17:197\u2013203.","journal-title":"Ann Nucl Med"},{"key":"251_CR38","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s00259-005-1876-y","volume":"33","author":"A Chao","year":"2006","unstructured":"Chao A, Chang TC, Ng KK, Hsueh S, Huang HJ, Chou HH, et al. FDG PET in the management of endometrial cancer. Eur J Nucl Med Mol Imaging 2006;33:36\u201344.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"251_CR39","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.ygyno.2004.05.053","volume":"94","author":"D Grisaru","year":"2004","unstructured":"Grisaru D, Almog B, Levine C, Metser U, Fishman A, Lerman H, et al. The diagnostic accuracy of FDG PET\/CT in patients with gynecological malignancies. Gynecol Oncol 2004;94:680\u20134.","journal-title":"Gynecol Oncol"},{"key":"251_CR40","first-page":"1602","volume":"45","author":"T Belhocine","year":"2004","unstructured":"Belhocine T. 18F-FDG PET imaging in posttherapy monitoring of cervical cancers: from diagnosis to prognosis. J Nucl Med 2004;45:1602\u20134.","journal-title":"J Nucl Med"},{"key":"251_CR41","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0090-8258(03)00336-6","volume":"90","author":"RE Bristow","year":"2003","unstructured":"Bristow RE, Del Carmen MG, Pannu HK, Cohade C, Zahurak ML, Fishman EK, et al. Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET\/CT. Gynecol Oncol 2003;90:519\u201328.","journal-title":"Gynecol Oncol"},{"key":"251_CR42","first-page":"412","volume":"44","author":"C Cohade","year":"2003","unstructured":"Cohade C, Osman M, Nakamoto Y, Marshall LT, Links JM, Fishman EK, et al. Initial experience with oral contrast in PET\/ CT: phantom and clinical studies. J Nucl Med 2003;44:412\u20136.","journal-title":"J Nucl Med"},{"key":"251_CR43","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1148\/radiol.2273020299","volume":"227","author":"Y Nakamoto","year":"2003","unstructured":"Nakamoto Y, Chin BB, Kraitchman DL, Lawler LP, Marshall LT, Wahl RL. Effects of nonionic intravenous contrast agents at PET\/CT imaging: phantom and canine studies. Radiology 2003;227:817\u201324.","journal-title":"Radiology"},{"key":"251_CR44","first-page":"1225","volume":"46","author":"RE Coleman","year":"2005","unstructured":"Coleman RE, Delbeke D, Guiberteau MJ, Conti PS, Royal HD, Weinreb JC, et al. Concurrent PET\/CT with an integrated imaging system: intersociety dialogue from the joint working group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance. J Nucl Med 2005;46:1225\u201339.","journal-title":"J Nucl Med"},{"key":"251_CR45","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1148\/radiol.2382041977","volume":"238","author":"GK Schulthess von","year":"2006","unstructured":"von Schulthess GK, Steinert HC, Hany TF. Integrated PET\/CT: current applications and future directions. Radiology 2006;238:405\u201322.","journal-title":"Radiology"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-006-0251-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-006-0251-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-006-0251-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T19:13:34Z","timestamp":1628104414000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-006-0251-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,16]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,3,14]]}},"alternative-id":["251"],"URL":"https:\/\/doi.org\/10.1007\/s00259-006-0251-y","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11,16]]}}}